Featured Content

William, McGivney, PhD
National Health Policy Expert

HHS Reissues Disputed 340B Policy on Orphan-drug Discounts

(Modern Healthcare) July 21, 2014 - HHS issued an interpretive rule (PDF) that requires drug companies to provide discounts on orphan drugs sold through a federal program just months after a judge struck down the government's previous version of the rule.

Commentary: The 340 B program continues to be yet another runaway train in the cancer care delivery system. With approximately...



OBR Daily   Our free daily oncology focused e-news service.
Subscribe»  |  Search Archives»

Today's News

New View of Stomach Cancer Could Hasten Better Therapies

(Dana-Farber) July 23, 2014 - In a massive effort to catalog the molecular causes of stomach cancer, scientists, including researchers from Dana-Farber Cancer Institute, have identified four subtypes of tumors based on shared mutations and other molecular abnormalities.
read press release »

Surgical Robot Fails to Show Advantages in Treating Bladder Cancer

(Wall Street Journal) July 23, 2014 - A new study finds treating bladder cancer with a surgical robot made by Intuitive Surgical is no better at reducing procedural complications than performing the procedure with traditional surgery, a result that surprised researchers, who had expected the robotic technology to be superior to human hands alone.
read article (paid subscription required) »

U.S. Paves Way for Novartis to Copy Amgen Biotech Drug

(Reuters) July 24, 2014 - U.S. regulators have accepted an application by Sandoz - the generics arm of Novartis - seeking approval for a copycat version of Amgen's drug Neupogen, or filgrastim, for patients with low white blood cell counts.
read article »

 

View ALL News »




News Story Commentary By Academic and Community Oncologists



HHS Reissues Disputed 340B Policy on Orphan-drug Discounts (Modern Healthcare)

The 340 B program continues to be yet another runaway train in the cancer care delivery system. With approximately...posted by: William, McGivney, PhD

Thumbs Up, Down for Study on New Cancer Pay Scheme (Medscape Medical News)

We all agree on one point: We cannot maintain the current level of cost increases in healthcare today, let alone...posted by: Winston, Wong, PharmD

Thumbs Up, Down for Study on New Cancer Pay Scheme (Medscape Medical News)

1)Incomplete data(@200 pts data not completed) 2)Co-ordination of care was a key driver of cost reduction 3)Cause...posted by: DrET

Payment and Delivery Reform Case Study: Cancer Care (Brookings Institution/Health Affairs Blog)

This is a very interesting presentation on the oncology medical home concept. This is now one of several programs...posted by: Thomas, Marsland, MD

Summary of 2015 Medicare Physician Fee Schedule Proposed Rule (ASH)

This ASH review gives a good synopsis of the proposed 2015 fee schedule. There appears to be be some silver linings...posted by: Thomas, Marsland, MD






OBR Training


Learn more about the OBR training platform, developed to provide an in-depth understanding of the unique business dynamics of today's oncology landscape.




OBR Job Board


Sunesis Pharmaceuticals, Inc. has 2 jobs posted.


Novocure has posted 4 jobs.


View OBR Job Board>>


IMS_White_300x250

The most comprehensive and up-to-date oncology pipeline information on the web!
OBR Pipeline Online™






View company profiles, indexes, and streaming stock quotes of over 200 oncology focused companies.

Winners/Losers

Symbol  %Δ
EXEL +11.38%
AGEN +11.15%
CBMG +7.53%
PBYI -8.79%
ONTY -6.99%
MNKD -5.86%


    


OBR Radar

View upcoming pivotal oncology events such as PDUFA dates, ODAC dates, and announcement of phase III clinical trial results


Date: July 22, 2014
Company: Puma Biotechnology
Product: neratinib (PB272)

Date: July 23, 2014
Company: Gilead Inc.
Product: Zydelig (idelalisib)

Date: mid-2014
Company: Threshold Pharmaceuticals / Merck KGaA
Product: TH-302

See All OBR Radar items»




OBR's Oncology Events Calendar is a compilation of important upcoming conferences and meetings that is updated daily.